Vaccine Increases the Diversity and Activation of Intratumoral T Cells in the Context of Combination Immunotherapy

SIMPLE SUMMARY: Innovative strategies to reduce immune suppression and activate tumor-specific immunity are needed to help patients who do not respond or become resistant to immune checkpoint blockade therapies. In this study, we demonstrate that the addition of a cancer vaccine targeting a tumor-as...

Descripción completa

Detalles Bibliográficos
Autores principales: Horn, Lucas A., Fousek, Kristen, Hamilton, Duane H., Hodge, James W., Zebala, John A., Maeda, Dean Y., Schlom, Jeffrey, Palena, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956439/
https://www.ncbi.nlm.nih.gov/pubmed/33669155
http://dx.doi.org/10.3390/cancers13050968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956439/
https://www.ncbi.nlm.nih.gov/pubmed/33669155
http://dx.doi.org/10.3390/cancers13050968

Ejemplares similares